Gain-of-function FGFR3 mutations have been shown to prolong FGFR3 signaling and disrupt proper chondrocyte proliferation and differentiation, leading to a group of skeletal dysplasias of varying severity (2). The gene discussed is FGFR3; the disease is skeletal dysplasia.